A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 75, Issue 1, 2010, Pages 26-32

  Trapani, Adriana ^a   Lopedota, Angela ^a   Franco, Massimo ^a   Cioffi, Nicola ^a   Ieva, Eliana ^a   Garcia Fuentes, Marcos ^b   Alonso, Maria José ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Chitosan; Cyclodextrins; Glutathione; Nanoparticles; Oral administration

Indexed keywords

CHITOSAN; CYCLODEXTRIN; GLUTATHIONE; NANOPARTICLE;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DUODENUM; EXPERIMENTAL MODEL; FROG; IN VITRO STUDY; INTESTINE EPITHELIUM; INTESTINE MUCOSA PERMEABILITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROTEIN TRANSPORT; X RAY PHOTOELECTRON SPECTROSCOPY;

ADMINISTRATION, ORAL; ANIMALS; CHITOSAN; CYCLODEXTRINS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GLUTATHIONE; INTESTINAL ABSORPTION; NANOPARTICLES; PEPTIDE FRAGMENTS; RANA ESCULENTA;

EID: 77951652367     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.01.010     Document Type: Article

References (30)

1. Langie S.S., Knaapen A.M., Houben J.M.J., van Kempen F.C., de Hoon J.P.J., Gottschalk R.W.H., Godschalk R.W.L., van Schooten F.J. The role of glutathione in the regulation of the nucleotide excision repair during oxidative stress. Toxicol. Lett. 2007, 168:302-309.
2. Martindale The Complete Drug Reference 2002, The Pharmaceutical Press, London, Great Britain, pp. 1010-1011. 33th ed.
3. H. Demopoulos, M.L. Seligman, PCT Int WO98/29101.
4. Camera E., Picardo M. Analytical methods to investigate glutathione and related compounds in biological and pathological processes. J. Chromatogr. B 2002, 781:181-206.
5. Tobio M., Sanchez A., Vila A., Soriano C., Evora J.L., Vila-Jato J.L., Alonso M.J. Investigations on the role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticle following oral administration. Colloids Surf. B: Biointerf. 2000, 18:315-32330.
6. Sandri G., Bonferoni M.C., Rossi S., Ferrari F., Gibin S., Zambito Y., Di Colo G., Caramella C. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models. Eur. J. Pharm. Biopharm. 2007, 65:68-77.
7. Lin Y.-H., Min F.-L., Chen C.-T., Chang W.-C., Peng S.-F., Liang H.-F., Sung H.-W. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules 2007, 8:146-152.
8. Fernandez-Urrusuno R., Romani D., Calvo P., Vila-J J.L., Alonso M.J. Development of freeze-dried formulation of insulin loaded chitosan nanoparticles intended for nasal administration. STP Pharma Sci. 1999, 9(5):429-436.
9. Pan Y., Li Y., Zhao H., Zheng J., Xu H., Wei G., et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int. J. Pharm. 2002, 249:139-147.
10. Zhang Y., Yang Y., Tang K., Hu X., Zou G. Physicochemical characterization and antioxidant activity of quercetin-loaded chitosan nanoparticles. J. Appl. Polym. Sci. 2008, 107:891-897.
11. Csaba N., Garcia-Fuentes M., Alonso M.J. The performance of nanocarriers for transmucosal drug delivery. Expert. Opin. 2006, 3(4):463-478.
12. Trapani A., Garcia-Fuentes M., Alonso M.J. Novel drug nanocarriers combining hydrophilic cyclodextrins and chitosan. Nanotechnology 2008, 19(18):185101/1-185101/10.
13. Krauland A.H., Alonso M.J. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system. Int. J. Pharm. 2007, 340:134-142.
14. Maestrelli F., Garcia-Fuentes M., Mura P., Alonso M.J. A new drug nanocarrier system consisting of chitosan and hydroxypropylcyclodextrin. Eur. J. Pharm. Biopharm. 2006, 63(2):79-86.
15. Teijeiro-Osorio D., Remuñan-Lopez C., Alonso M.J. Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro. Eur. J. Pharm. Biopharm. 2009, 71:257-263.
16. Teijeiro-Osorio D., Remuñan-Lopez C., Alonso M.J. New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules. Biomacromolecules 2009, 10(2):243-249.
17. Garcia-Fuentes M., Trapani A., Alonso M.J. Protection of the peptide glutathione by complex formation with α-cyclodextrin: NMR spectroscopic analysis and stability study. Eur. J. Pharm. Biopharm. 2006, 64:146-153.
18. Calvo P., Remuñan-Lopez C., Vila-J J.L., Alonso M.J. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 1997, 63:125-132.
19. Ieva E., Trapani A., Cioffi N., Ditaranto N., Monopoli A., Sabbatini L. Analytical characterization of chitosan nanoparticles for peptide drug delivery applications. Anal. Bioanal. Chem. 2009, 393:207-215.
20. Da Silveira A.M., Ponchel G., Puisieux F., Duchene D. Combined poly(isobutylcyanoacrilate) and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs. Pharm. Res. 1998, 15:1051-1055.
21. Lopedota A., Trapani A., Cutrignelli A., Chiarantini L., Pantucci E., Curci R., Manuali E., Trapani G. The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione. Eur. J. Pharm. Biopharm. 2009, 72:509-520.
22. Ma Z., Lim T.M., Lim L.-Y. Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats. Int. J. Pharm. 2005, 293:271-280.
23. Janes K.A., Calvo P., Alonso M.J. Polysaccharide colloidal nanoparticles as delivery systems for macromolecules. Adv. Drug Deliv. Rev. 2001, 47:83-97.
24. Aktas Y., Andrieux K., Alonso M.J., Calvo P., Gursoy R.N., Couvreur P., Capan Y. Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor. Int. J. Pharm. 2005, 298:378-383.
25. Kommareddy S., Amiji M. Poly(ethylene glycol)-modified thiolated gelatine nanoparticles for glutathione-responsive intracellular DNA delivery. Nanomedicine 2007, 3:32-42.
26. 2S by iron oxides in unsaturated conditions. Environ. Sci. Technol. 2003, 37:2192-2199.
27. Hamidi M., Azadi A., Rafiei P. Hydrogel nanoparticles in drug delivery. Adv. Drug Deliv. Rev. 2008, 60:1638-1649.
28. Franco M., Lopedota A., Trapani A., Cutrignelli A., Meleleo D., Micelli S., Trapani G. Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: application to carrier transported drugs. Int. J. Pharm. 2008, 352:182-188.
29. Trapani G., Franco M., Trapani A., Lopedota A., Latrofa A., Gallucci E., Micelli S., Liso G. Frog intestinal sac: a new in vitro method for the assessment of intestinal permeability. J. Pharm. Sci. 2004, 93:2909-2919.
30. Csaky T.Z., Gallucci E. Seasonal variation in the active transporting ability and in the membrane ATPase activity of the frog intestinal epithelium. Biochim. Biophys. Acta 1977, 466:521-525.